PB Ratio of Nath Bio-genes (india) Ltd
Nath Bio-Genes (India) Ltd
NSE: NATHBIOGEN
PB Ratio
Key Highlights
- The latest PB Ratio of Nath Bio-Genes (India) Ltd is 0.4.
- The PB ratio of the Nath Bio-Genes (India) Ltd is below 1 which indicates that the stock is undervalued.
- The P/B Ratio of Nath Bio-Genes (India) Ltd changed from 0.8 on March 2022 to 0.4 on March 2025 . This represents a CAGR of -15.91% over 4 years.
Historical P/B Ratio of Nath Bio-Genes (India) Ltd
The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share. How to calculate Price-to-Book (P/B) Ratio? The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company. Market capitalization = market value of a stock X no. of outstanding shares Now, you need to know the net value of an organization's assets. Book Value of Assets = Total Assets - Total Liabilities of a company After knowing the value of the above ratios, here is the formula for the P/B Ratio: P/B Ratio = Market Capitalization/ Book Value of Assets or you can also use this formula P/B ratio = Market Price Per Share/ Book Value of Asset Per Share
Historical P/B Ratio of Nath Bio-Genes (India) Ltd
Company Fundamentals for Nath Bio-Genes (India) Ltd
Market Cap
283 Cr
EPS
20.5
P/E Ratio (TTM)
7.3
P/B Ratio (TTM)
0.4
Day’s High
151.8
Day’s Low
147.95
DTE
0.2
ROE
6.8
52 Week High
238.0
52 Week Low
138.0
ROCE
7.4
Market Price of Nath Bio-Genes (India) Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 03 Feb 2026 | 149 |
| 02 Feb 2026 | 148.9 |
| 01 Feb 2026 | 145.45 |
| 30 Jan 2026 | 145.35 |
| 29 Jan 2026 | 143.2 |
| 28 Jan 2026 | 141.8 |
| 27 Jan 2026 | 141.9 |
| 23 Jan 2026 | 142 |
| 22 Jan 2026 | 146.15 |
| 21 Jan 2026 | 140.95 |
SWOT Analysis Of Nath Bio-Genes (India) Ltd
BlinkX Score for Nath Bio-Genes (India) Ltd
Asset Value vs Market Value of Nath Bio-Genes (India) Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/B Ratio
| Company | PB | Market Cap |
|---|
| Nath Bio-Genes (India) Ltd | 0.42 | 283.16 |
| Hindustan Unilever Ltd | 207.4 | 556700 |
| Nestle India Ltd | 23.8 | 252445 |
| Varun Beverages Ltd | 54.1 | 152629 |
| Britannia Industries Ltd | 136.2 | 141639 |
| Company | |
|---|---|
| Nath Bio-Genes (India) Ltd | 0.42 |
| Hindustan Unilever Ltd | 207.4 |
| Nestle India Ltd | 23.8 |
| Varun Beverages Ltd | 54.1 |
| Britannia Industries Ltd | 136.2 |
PB Ratio of Nath Bio-Genes (India) Ltd Explained
₹283.16
Market cap
₹358
Book Value per Share
0.4X
PB Ratio
Historical Market Cap of Nath Bio-Genes (India) Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Nath Bio-Genes (India) Ltd
Market Cap
Historical Revenue, EBITDA and Net Profit of Nath Bio-Genes (India) Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Nath Bio-Genes (India) Ltd
Revenue
EBITDA
Net Profit
Dividend Payout Over Time
Nath Bio-Genes (India) Ltd News Hub
Nath Bio-Genes (India) consolidated net profit declines 0.24% in the June 2024 quarter
Net profit of Nath Bio-Genes (India) declined 0.24% to Rs 33.35 crore in the quarter ended June 2024
Read more
07 Aug 24
Nath Bio-Genes (India) announces board meeting date
Nath Bio-Genes (India) will hold a meeting of the Board of Directors of the Company on 23 October 20
Read more
17 Oct 24
Nath Bio-Genes (India) standalone net profit rises 79.50% in the September 2024 quarter
Net profit of Nath Bio-Genes (India) rose 79.50% to Rs 2.89 crore in the quarter ended September 202
Read more
23 Oct 24
Nath Bio-Genes (India) consolidated net profit declines 26.49% in the September 2024 quarter
Net profit of Nath Bio-Genes (India) declined 26.49% to Rs 1.11 crore in the quarter ended September
Read more
23 Oct 24
